39 related articles for article (PubMed ID: 38501829)
1. Importations of SARS-CoV-2 lineages decline after nonpharmaceutical interventions in phylogeographic analyses.
Goliaei S; Foroughmand-Araabi MH; Roddy A; Weber A; Översti S; Kühnert D; McHardy AC
Nat Commun; 2024 Jun; 15(1):5267. PubMed ID: 38902246
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Pediatric Parainfluenza Virus Infections: A Comparative Analysis of Parainfluenza Virus Serotypes 1-4 From April 2021 to October 2023 in Hokkaido, Japan.
Sanada A; Kondo K; Takahashi F; Higashide Y; Kunizaki J; Hoshino E; Sakurai N; Mori T
Pediatr Infect Dis J; 2024 Jun; ():. PubMed ID: 38900074
[TBL] [Abstract][Full Text] [Related]
3. Current status of vaccines for parainfluenza virus infections.
Sato M; Wright PF
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S123-5. PubMed ID: 18820572
[TBL] [Abstract][Full Text] [Related]
4. Phylogenetic lineage dynamics of global parainfluenza virus type 3 post-COVID-19 pandemic.
Lee K; Park K; Sung H; Kim M-N
mSphere; 2024 Apr; 9(4):e0062423. PubMed ID: 38501829
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of human parainfluenza virus type 3 obtained in Croatia, 2011-2015.
Košutić-Gulija T; Slovic A; Ljubin-Sternak S; Mlinarić-Galinović G; Forčić D
J Med Microbiol; 2017 Apr; 66(4):502-510. PubMed ID: 28463659
[TBL] [Abstract][Full Text] [Related]
6. Sequence determination of the hemagglutinin-neuraminidase (HN) gene of human parainfluenza type 2 virus and the construction of a phylogenetic tree for HN proteins of all the paramyxoviruses that are infectious to humans.
Kawano M; Bando H; Yuasa T; Kondo K; Tsurudome M; Komada H; Nishio M; Ito Y
Virology; 1990 Jan; 174(1):308-13. PubMed ID: 2152995
[TBL] [Abstract][Full Text] [Related]
7. Genetic Analysis of HPIV3 That Emerged during the SARS-CoV-2 Pandemic in Gwangju, South Korea.
Lee H; Kim SH; Cho SJ; Lee YU; Lee K; Lee YP; Seo J; Chung YS
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891425
[TBL] [Abstract][Full Text] [Related]
8. Genetic diversity and evolutionary analysis of human respirovirus type 3 strains isolated in Kenya using complete hemagglutinin-neuraminidase (HN) gene.
Elusah J; Bulimo WD; Opanda SM; Symekher SL; Wamunyokoli F
PLoS One; 2020; 15(3):e0229355. PubMed ID: 32155160
[TBL] [Abstract][Full Text] [Related]
9. Reemergence of Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections During the COVID-19 Pandemic.
Park K; Sung H; Kim MN
Ann Lab Med; 2023 Jan; 43(1):114-116. PubMed ID: 36045068
[No Abstract] [Full Text] [Related]
10. Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control.
Lee SS; Viboud C; Petersen E
Int J Infect Dis; 2022 Sep; 122():1002-1004. PubMed ID: 35932966
[No Abstract] [Full Text] [Related]
11. Phylogenetic analysis of human parainfluenza type 3 virus strains responsible for the outbreak during the COVID-19 pandemic in Seoul, South Korea.
Kim HN; Yoon SY; Lim CS; Lee CK; Yoon J
J Clin Virol; 2022 Aug; 153():105213. PubMed ID: 35724578
[TBL] [Abstract][Full Text] [Related]
12. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions.
Eden JS; Sikazwe C; Xie R; Deng YM; Sullivan SG; Michie A; Levy A; Cutmore E; Blyth CC; Britton PN; Crawford N; Dong X; Dwyer DE; Edwards KM; Horsburgh BA; Foley D; Kennedy K; Minney-Smith C; Speers D; Tulloch RL; Holmes EC; Dhanasekaran V; Smith DW; Kok J; Barr IG;
Nat Commun; 2022 May; 13(1):2884. PubMed ID: 35610217
[TBL] [Abstract][Full Text] [Related]
13. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination.
Dhanasekaran V; Sullivan S; Edwards KM; Xie R; Khvorov A; Valkenburg SA; Cowling BJ; Barr IG
Nat Commun; 2022 Mar; 13(1):1721. PubMed ID: 35361789
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
